First Manhattan’s Integra LifeSciences IART Stock Holding History

First Manhattan’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,848	Closed	-$117K	–	1401
2016 Q3	$117K	Sell	2,848 -560	-16%	-$23.5K	﹤0.01%	767
2016 Q2	$135K	Buy	+3,408	New	+$123K	﹤0.01%	751
2014 Q1	–	Sell	-2,446	Closed	-$47K	–	1427
2013 Q4	$47K	Buy	+2,446	New	+$44.9K	﹤0.01%	959

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

First Manhattan's IART Position: Q4 2016 in Review

First Manhattan sold out of Integra LifeSciences (IART) in Q4 2016, closing a stake of 2,848 shares — an estimated $117K sold.

First Manhattan first reported a position in IART in Q4 2013 and held it in 3 quarters. The position peaked at $135K in Q2 2016. 223 funds tracked by Wall St. Rank hold IART as of Q4 2016.

First Manhattan reported no remaining Integra LifeSciences position as of Q4 2016 after selling out during the quarter.
First Manhattan sold 2,848 Integra LifeSciences shares in Q4 2016, an estimated $117K.
First Manhattan first reported a position in Integra LifeSciences in Q4 2013 and held it in 3 quarters.
First Manhattan's Integra LifeSciences position peaked at $135K in Q2 2016.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.

Based on First Manhattan's 13F filing for Q4 2016, filed 25 Jan 2017.